跳轉至內容
Merck
  • Haspin inhibition delays cell cycle progression through interphase in cancer cells.

Haspin inhibition delays cell cycle progression through interphase in cancer cells.

Journal of cellular physiology (2019-10-19)
Peiling Wang, Xiangmei Hua, Yuge Han Bryner, Sijing Liu, Christopher B Gitter, Jun Dai
摘要

Haspin (Haploid Germ Cell-Specific Nuclear Protein Kinase) is a serine/threonine kinase pertinent to normal mitosis progression and mitotic phosphorylation of histone H3 at threonine 3 in mammalian cells. Different classes of small molecule inhibitors of haspin have been developed and utilized to investigate its mitotic functions. We report herein that applying haspin inhibitor CHR-6494 or 5-ITu at the G1/S boundary could delay mitotic entry in synchronized HeLa and U2OS cells, respectively, following an extended G2 or the S phase. Moreover, late application of haspin inhibitors at S/G2 boundary is sufficient to delay mitotic onset in both cell lines, thereby, indicating a direct effect of haspin on G2/M transition. A prolonged interphase duration is also observed with knockdown of haspin expression in synchronized and asynchronous cells. These results suggest that haspin can regulate cell cycle progression at multiple stages at both interphase and mitosis.

材料
產品編號
品牌
產品描述

Sigma-Aldrich
抗磷酸组蛋白H2A.X(Ser139)抗体,克隆JBW301, clone JBW301, Upstate®, from mouse
Sigma-Aldrich
抗 α-微管蛋白单克隆抗体 小鼠抗, clone DM1A, ascites fluid
Sigma-Aldrich
抗-γ-微管蛋白 兔抗, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Anti-phospho-Histone H3 (Thr3) Antibody, clone JY325, rabbit monoclonal, culture supernatant, clone JY325, Upstate®